$2.83
-0.06 (-2.08%)
Open$2.89
Previous Close$2.89
Day High$2.90
Day Low$2.81
52W High$4.66
52W Low$2.81
Volume—
Avg Volume185.8K
Market Cap1.61B
P/E Ratio—
EPS$0.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+955.8% upside
Current
$2.83
$2.83
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 218.06M | 186.63M | 608.59M |
| Net Income | -14,031,735 | -10,808,423 | 77.66M |
| Profit Margin | -6.4% | -6.1% | 12.8% |
| EBITDA | -22,701,751 | -18,458,287 | 120.12M |
| Free Cash Flow | — | — | 67.66M |
| Rev Growth | +16.8% | +16.8% | +15.9% |
| Debt/Equity | — | — | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |